Rational Coformer Selection in the Development of 6-Propyl-2-thiouracil Pharmaceutical Cocrystals

Author:

Acebedo-Martínez Francisco Javier1ORCID,Alarcón-Payer Carolina2ORCID,Verdugo-Escamilla Cristóbal1ORCID,Martín Jesús3,Frontera Antonio4ORCID,Domínguez-Martín Alicia5ORCID,Gómez-Morales Jaime1ORCID,Choquesillo-Lazarte Duane1ORCID

Affiliation:

1. Laboratorio de Estudios Cristalográficos, IACT, CSIC-Universidad de Granada, Avda. de las Palmeras 4, 18100 Armilla, Spain

2. Servicio de Farmacia, Hospital Universitario Virgen de las Nieves, 18014 Granada, Spain

3. Fundación MEDINA, Centro de Excelencia en Investigación de Medicamentos Innovadores en Andalucía, Parque Tecnológico Ciencias de la Salud, Avda. del Conocimiento 34, 18016 Armilla, Spain

4. Department of Chemistry, Universitat de les Illes Balears, Crta de Valldemossa km 7.5, 07122 Palma de Mallorca (Baleares), Spain

5. Department of Inorganic Chemistry, Faculty of Pharmacy, University of Granada, 18071 Granada, Spain

Abstract

Pharmaceutical multicomponent solids have proved to efficiently modulate the physicochemical properties of active pharmaceutical ingredients. In this context, polyphenols are interesting coformers for designing pharmaceutical cocrystals due to their wide safety profile and interesting antioxidant properties. The novel 6-propyl-2-thiouracil multicomponent solids have been obtained by mechanochemical synthesis and fully characterized by powder and single-crystal X-ray diffraction methods. The analysis of supramolecular synthons has been further performed with computational methods, with both results revealing a robust supramolecular organization influenced by the different positions of the hydroxyl groups within the polyphenolic coformers. All novel 6-propyl-2-thiouracil cocrystals show an enhanced solubility profile, but unfortunately, their thermodynamic stability in aqueous media is limited to 24 h.

Funder

FEDER-Universidad de Granada, Spain

MICIU/AEI of Spain

Publisher

MDPI AG

Subject

Drug Discovery,Pharmaceutical Science,Molecular Medicine

Reference64 articles.

1. Goth, A. (1978). Medical Pharmacology, The C.V. Company Mosby. [9th ed.].

2. U.S. Food and Drug Administration (2023, January 18). Propylthiouracil Information, Available online: https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/propylthiouracil-information.

3. Structure of a Potent Antithyroid Drug, 6-Propyl-2-thiouracil;Okabe;Bull. Chem. Soc. Jpn.,1983

4. Mechanism of Action of Thioureylene Antithyroid Drugs in the Rat: Possible Inactivation of Thyroid Peroxidase by Propylthiouracil;Shiroozu;Endocrinology,1983

5. Inhibitory Effects of Methimazole and Propylthiouracil on Iodotyrosine Deiodinase 1 in Thyrocytes;Yoshihara;Endocr. J.,2019

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3